Suicide‐Related Medical Claims, Downstream Healthcare Costs, and the Economic Impact of Enhanced Outpatient Services
Suicide and Life-Threatening Behavior · 2026-12 · 56 (6)
DOI: 10.1111/sltb.70148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Suicide and Life-Threatening Behavior, online erschienen am 04.11.2026. Verfasst von Scott Graupensperger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Spring Health, New York, New York, USA. Hauptthemen laut MEDLINE: Health Care Costs, Mental Health Services, Ambulatory Care, Suicide. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Suicide‐related medical claims are often followed by sustained healthcare utilization. This study quantified post‐crisis cost trajectories and examined whether coordinated outpatient mental health care was associated with lower downstream spending.
Methods
We analyzed longitudinal medical claims from 13 employers. In Aim 1, individuals with a suicide‐related claim ( n = 5574) were matched to demographically and clinically similar controls without such claims ( n = 16,632). In Aim 2, individuals who used an employer‐sponsored mental health program within 1 month of a suicide‐related claim ( n = 248) were matched to non‐users ( n = 248).
Results
Relative to matched controls, individuals with suicide‐related claims incurred more than double the monthly costs during the year following the suicide‐related claim, corresponding to adjusted excess of $547 per month ($6564 annually), not including the month of the index claim. Among those with a suicide‐related claim, early program engagement was associated with 37% lower monthly spending over Months 1–12 post‐claim ($720 less per month; $8637 annually).
Conclusions
Suicide‐related claims are associated with sustained economic burden for employers and health plans. Early coordinated outpatient mental health care was associated with lower subsequent healthcare spending, especially spending in acute, high‐cost settings. These findings highlight the potential economic value of structured behavioral health services following suicide‐related claims.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Spring Health, New York, New York, USA.
- Yale School of Medicine, Psychiatry, New Haven, Connecticut, USA.
ORCID-Profile: Scott Graupensperger, Adam Chekroud
Zitieren
APA
Graupensperger, S., Bentley, K. H., Brown, M., Chekroud, A., & Hawrilenko, M. (2026). Suicide‐Related Medical Claims, Downstream Healthcare Costs, and the Economic Impact of Enhanced Outpatient Services. Suicide and Life-Threatening Behavior, 56(6). https://doi.org/10.1111/sltb.70148
Vancouver
Graupensperger S, Bentley KH, Brown M, Chekroud A, Hawrilenko M. Suicide‐Related Medical Claims, Downstream Healthcare Costs, and the Economic Impact of Enhanced Outpatient Services. Suicide and Life-Threatening Behavior. 2026;56(6). doi:10.1111/sltb.70148
BibTeX
@article{Graupensperger2026,
author = {Graupensperger, Scott and Bentley, Kate H and Brown, Millard and Chekroud, Adam and Hawrilenko, Matt},
title = {Suicide‐Related Medical Claims, Downstream Healthcare Costs, and the Economic Impact of Enhanced Outpatient Services},
journal = {Suicide and Life-Threatening Behavior},
year = {2026},
volume = {56},
number = {6},
doi = {10.1111/sltb.70148}
}
EUVIMED